Certara is a leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development. The company provides services to biopharmaceutical and generic drug companies, academic institutions, and regulatory agencies. Certara's solutions include biosimulation, regulatory science, and market access. The company's biosimulation solutions include physiologically-based pharmacokinetic (PBPK) modeling and simulation, quantitative systems pharmacology (QSP) modeling and simulation, and population pharmacokinetic (PopPK) modeling and simulation. Certara's regulatory science solutions include clinical pharmacology, pharmacometrics, and regulatory writing. The company's market access solutions include health economics and outcomes research (HEOR) and real-world evidence (RWE) generation.